Neuraxis, INC (NRXS) income statement
NRXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 0/30
$4.22−0.28 (-6.22%)
Close on Nov 20, 2026Market cap $52.99MP/E –Yield –
Neuraxis, INC income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 85.6%
- Operating margin
- -144.5%
- Net margin
- -144.4%
- Return on equity, FY2025
- -285.4%
Financial strength
- Current ratio
- 3.04
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 268.8%
Valuation
- P/E ratio
- –
- Price to sales
- 9.97
- Price to book
- 7.87
- Dividend yield
- –
See a number that looks wrong?